Capricor Therapeutics (CAPR) Reports Q2 Loss of $0.59

August 6, 2019 4:54 PM

Capricor Therapeutics (NASDAQ: CAPR) reported Q2 EPS of ($0.59), versus ($1.42) reported last year. Revenue for the quarter came in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found